Breaking News, Collaborations & Alliances

CDMO Famar and Active Biotech Ink Clinical Manufacturing Deal

Will deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Active Biotech AB has reached a manufacturing agreement with Famar Health Care Services Madrid SAU, a European provider of pharmaceutical manufacturing and development services. Famar will deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.   The new formulation is developed by Active Biotech together with Leukocare AG, a biotechnology company from Munich, Germany, specialized in pharmaceutical formulation development. The formulation will be studied for th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters